The big buzz around AI in healthcare is the potential it holds to identify and even create new drugs. “AI drug discovery” is the great new hope. And – despite critics awkwardly pointing out that no AI-generated drugs have yet been approved by any regulator, and vanishing few appear to be close to that finishing […]
AMSilk Secures EUR 52M Strategic Financing to Accelerate Commercial Growth AMSilk GmbH has successfully secured EUR 52 million financing led by existing investor ATHOS (AT Newtec), along with strong participation from fellow existing investors MIG Capital and Novo Holdings. The financing will enable AMSilk to scale industrial production and meet global customer demand for its […]
If AstraZeneca’s ditching of its plans last January for a long-expected £450 million investment in a vaccine manufacturing in Liverpool was a bright red warning sign, then Merck’s decision this week to can a half-built £1bn research centre in London is a car crash. Pharma executives have been warning the UK’s government ever since it […]
ViCentra raises $85M to scale manufacturing and accelerate market penetration of Kaleido insulin patch pump ViCentra announces the successful close of an upsized $85 million Series D financing led by new investor Innovation Industries, a leading European deeptech venture capital firm, with matching participation from existing investors Partners in Equity and Invest-NL, alongside continued support from […]
September is World Alzheimer’s Month, and while advances in treatment of the degenerative brain disease have been big news over the last couple of years, it is worth reflecting on the wider picture. Alzheimer’s – together with other forms of dementia – become much more frequent as people age. The growing incidence of dementia worldwide […]
